Search research articles
Contact Us
Filters
Showing results (351-360 of 686) with videos related to
Page
of 69
Sort By:
BMC Musculoskeletal Disorders
|
December 3, 2005
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]
Sean P Curtis, Barry Bockow, Chester Fisher, et al.
JAMA
|
July 16, 2002
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
Dennis T Ko, Patricia R Hebert, Christopher S Coffey, et al.
Environmental Science & Technology
|
February 22, 2020
Enrichment of Nitrogen-Fixing Bacteria in a Nitrogen-Deficient Wastewater Treatment System
Carolina Ospina-Betancourth, Kishor Acharya, Ben Allen, et al.
Hybridoma
|
July 1, 1986
Chimeric antibodies with 17-1A-derived variable and human constant regions
L K Sun, P Curtis, E Rakowicz-Szulczynska, et al.
Applied Microbiology and Biotechnology
|
February 25, 2011
Evaluation of hydrolysis and fermentation rates in microbial fuel cells
Sharon B Velasquez-Orta, Eileen Yu, Krishna P Katuri, et al.
FEMS Microbiology Ecology
|
September 2, 2009
Composition and diversity of ammonia-oxidising bacterial communities in wastewater treatment reactors of different design treating identical wastewater
Arlene K Rowan, Jason R Snape, David Fearnside, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
September 10, 2002
A comparison of autotrophic ammonia-oxidizing bacteria in full- and laboratory-scale wastewater treatment reactors
A K Rowan, J R Snape, D Fearnside, et al.
Clinical Endocrinology
|
June 1, 1993
Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11 beta-hydroxysteroid dehydrogenase
A E Michael, L A Pester, P Curtis, et al.
Clinical Therapeutics
|
March 5, 2004
Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials
Sean P Curtis, Jennifer Ng, Qinfen Yu, et al.
Current Medical Research and Opinion
|
June 25, 2005
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis
Dena R Ramey, Douglas J Watson, Chang Yu, et al.
Page
of 69
Search research articles
Search
Showing results (351-360 of 686) with videos related to
Sort By:
Page
of 69
BMC Musculoskeletal Disorders
|
December 3, 2005
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]
Sean P Curtis, Barry Bockow, Chester Fisher, et al.
JAMA
|
July 16, 2002
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
Dennis T Ko, Patricia R Hebert, Christopher S Coffey, et al.
Environmental Science & Technology
|
February 22, 2020
Enrichment of Nitrogen-Fixing Bacteria in a Nitrogen-Deficient Wastewater Treatment System
Carolina Ospina-Betancourth, Kishor Acharya, Ben Allen, et al.
Hybridoma
|
July 1, 1986
Chimeric antibodies with 17-1A-derived variable and human constant regions
L K Sun, P Curtis, E Rakowicz-Szulczynska, et al.
Applied Microbiology and Biotechnology
|
February 25, 2011
Evaluation of hydrolysis and fermentation rates in microbial fuel cells
Sharon B Velasquez-Orta, Eileen Yu, Krishna P Katuri, et al.
FEMS Microbiology Ecology
|
September 2, 2009
Composition and diversity of ammonia-oxidising bacterial communities in wastewater treatment reactors of different design treating identical wastewater
Arlene K Rowan, Jason R Snape, David Fearnside, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research
|
September 10, 2002
A comparison of autotrophic ammonia-oxidizing bacteria in full- and laboratory-scale wastewater treatment reactors
A K Rowan, J R Snape, D Fearnside, et al.
Clinical Endocrinology
|
June 1, 1993
Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11 beta-hydroxysteroid dehydrogenase
A E Michael, L A Pester, P Curtis, et al.
Clinical Therapeutics
|
March 5, 2004
Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials
Sean P Curtis, Jennifer Ng, Qinfen Yu, et al.
Current Medical Research and Opinion
|
June 25, 2005
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis
Dena R Ramey, Douglas J Watson, Chang Yu, et al.
Page
of 69